VIENNA, Austria: At its press conference on Thursday morning, Switzerland-based company Nobel Biocare announced the next step in its digital workflow with a new option for same-day guided surgery made possible by DTX Studio Implant and the X-Guide dental navigation system. In addition, the company is introducing creos mucogain, a resorbable collagen matrix for soft-tissue regeneration, as well as the NobelPro Line, in order to highlight the possibilities of Nobel Biocare’s comprehensive range of edentulous treatment solutions.
With X-Guide, being demonstrated at the fully equipped Nobel Biocare lounge by Dr Pascal Kunz, clinicians have a new treatment option for same-day surgery. DTX Studio Implant empowers this innovative system for dynamic 3-D navigation. With the software officially being launched for European markets at the EAO congress, treatment plans from DTX Studio Implant (formerly NobelClinician) can now be instantly delivered to the patient, providing a workflow for diagnostics, implant planning and dynamically navigated implant surgeries, even during emergency interventions where computer-assisted surgeries until now could not be fully applied.
Using DTX Studio Implant and X-Guide, clinicians can achieve high-precision, shorter time-to-teeth treatments, including screw-retained provisionalisation with full 3-D control of their implant site preparation and dynamically monitored implant insertion. The procedure only takes minutes from the CBCT scanning to the start of the surgery. Similar to a GPS in a car, X-Guide provides stable, lag-free, real-time 3-D intra-oral guidance of the drill and implant position in relation to patient anatomy. X-Guide is manufactured by X-Nav Technologies, a North America-based innovator in dental 3-D navigation who has exclusively partnered with Nobel Biocare.
Hans Geiselhöringer, President of Nobel Biocare, welcomed media and industry partners to the company’s press conference on 11 October 2018. (Photograph: Nobel Biocare)
Hans Geiselhöringer, President of Nobel Biocare (Photograph: Nobel Biocare)
Many international media and industry partners gathered for the conference. (Photograph: Monique Mehler, DTI)
(Photograph: Monique Mehler)
Tinne Van Delm (left), Head Global Product Management Software at Nobel Biocare, and Dr Kunz showcased the multiple software solutions that the company offers in its extensive portfolio. (Photograph: Monique Mehler, DTI)
Together with Dr Kunz (left), X-Nav Co-Founder, President and CEO Ed Marandola demonstrated the X-Guide. (Photograph: Monique Mehler, DTI)
Dr Kunz showed how the calibration of the instruments works. (Photograph: Monique Mehler, DTI)
Media and industry partners had the chance to network whilst enjoying a variety of coffee specialities and pastries. (Photograph: Monique Mehler, DTI)
A barista and multiple waiters ensured the well-being of the Nobel Biocare press conference attendees. (Photograph: Monique Mehler, DTI)
Extending Nobel Biocare’s range of solutions for guided bone and tissue regeneration, the new creos mucogain resorbable collagen matrix is intended to be used as an alternative for autologous soft-tissue grafts in various soft-tissue indications, such as soft-tissue volume augmentation and root coverage in submerged healing. Composed of highly purified porcine collagen and elastin fibres, it has an open interconnecting porous structure designed to promote soft-tissue regeneration through the migration of cells and blood vessels into the matrix.1, 2
The matrix offers high stress resistance and suture retention2 that is sufficient for the tunnelling technique.3 Owing to a memory effect, it retains its initial volume when hydrated.2 Creos mucogain is available in different sizes (15 × 20 mm and 25 × 30 mm) and thicknesses (3 and 5 mm). According to Nobel Biocare, it offers excellent handling, as it can be used directly out of the packaging and trimmed to precisely fit the surgical site.3
Highlighting its range of edentulous treatment solutions, Nobel Biocare is further announcing the NobelPro Line to showcase the benefits of immediate function, along with the latest advancements in minimally invasive care. With an assortment of clinically successful and proven treatment options, including NobelSpeedy and NobelZygoma, clinicians can take the All-on-4 treatment concept to new heights and treat even the most challenging maxillary cases with moderate up to severe resorption.
At the press conference, President of Nobel Biocare Hans Geiselhöringer said, “Nobel Biocare has once again shown that it is a leading force in bringing cutting-edge technology and solutions to clinicians worldwide. With the addition of dynamic navigation to its digital workflow, Nobel Biocare looks forward to helping more clinicians leverage the latest in implant treatment technology. Together with forward-looking regenerative solutions like creos mucogain as well as the NobelPro Line, they now have better treatment options available to lead more patients to immediate function and excellent aesthetics.”
Clinical insights on X-Guide, creos mucogain and the NobelPro Line will be given during clinical lectures and hands-on courses presented by Nobel Biocare in Vienna. More information is available at Booth D02 and online at http://www.nobelbiocare.com/eao.
References
- Boekema BK, Vlig M, Olde Damink L, Middelkoop E, Eummelen L, Bühren AV, Ulrich MM. Effect of pore size and cross-linking of a novel collagen-elastin dermal substitute on wound healing. J Mater Sci Mater Med. 2014 Feb;25(2):423–33.
- Olde Damink L, Heschel I, Leemhuis H, Tortorici M, Wessing B. Soft tissue volume augmentation in the oral cavity with a collagen-based 3D matrix with orientated open pore structure. CDBME. 2018 Sep;4(1):237–41.
- Wessing B, Vasilic N. Soft tissue augmentation with a new regenerative collagen 3-D matrix with oriented open pores as a potential alternative to autologous connective tissue grafts. Clin Oral Implants Res. 2014;25(10 Suppl):342. Available from: dentalcongressposters.com/eao2014/wessing.pdf.
Tags:
MADRID, Spain: True science, original solutions and real innovations await visitors to the Nobel Biocare booth (hall 9, section D3) at the 2017 annual ...
PARIS, France: At the congress of the European Association for Osseointegration (EAO), currently being held in Paris, dental implants manufacturer Nobel ...
AMSTERDAM, Netherlands: Recent trends in dental implantology have indicated increasing patient demand for ceramic-based solutions with the appearance and ...
AMSTERDAM, Netherlands: The latest findings and the newest solutions for hard- and soft-tissue health and regeneration are hot topics. Attendees can join ...
BREA, Calif., U.S.: Envista is proud to announce the 2020 Nobel Biocare Global Symposium, to be held in Las Vegas from April 16 to 18. Empowered by a ...
LISBON, Portugal: This year, Nobel Biocare opened a new chapter for implant dentistry with the launch of new surfaces and the introduction of the new Nobel ...
SINGAPORE: At IDEM Singapore, which is taking place this weekend, from 13 to 15 April, visitors can see Nobel Biocare’s new full-arch solution in action: ...
LOS ANGELES, U.S.: SprintRay, a 3D printer manufacturer that focuses on digital dentistry, announced last week that it has commenced a partnership with the ...
ZURICH, Switzerland: Peri-implantitis is one of the greatest unsolved problems in dental implantology, and its prevalence is expected to increase over time ...
ZURICH, Switzerland: Nobel Biocare and DOCERAM Medical Ceramics are combining their strengths in order to offer high-quality restorative solutions which ...
Dr. Annette Felderhoff-Fischer
Dr. Rafael Saviolo Moreira
Dr. Ian Lane Dip SED, BDS (Hons) (Ncl), MFGDP, MSc, KOIS Graduate
To post a reply please login or register